Europe PMCopen access
Short-term effects of ocrelizumab on cortical pathology in patients with multiple sclerosis
Multiple sclerosis, Cortical Lesions, Ocrelizumab, Aidir
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 307864
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.